Enoxacin in the therapy of anal and pharyngeal gonococcal infections.

Abstract

In this randomized double-blind study, 51 patients with uncomplicated anal or pharyngeal Neisseria gonorrhoeae infection were evaluated to determine the efficacy and safety of 200- or 400-mg of enoxacin twice a day for two days. Enoxacin cured all anal infections and 12 out of 13 pharyngeal infections. All 82 isolates of N. gonorrhoeae tested were inhibited by 1 microgram of enoxacin/ml.

• Authors: B Romanowski, J S Hardy, M S Rafter, J Draker
• Journal: Sexually transmitted diseases (Sex Transm Dis) 1989 Oct-Dec Vol. 16 Issue 4 Pg. 190-1 ISSN: 0148-5717 [Print] United States
• PMID: 2688147 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Enoxacin

Topics

• Administration, Oral
• Adolescent
• Adult
• Dose-Response Relationship, Drug
• Double-Blind Method
• Enoxacin (administration & dosage)
• Female
• Gonorrhea (drug therapy)
• Humans
• Male
• Pharyngitis (drug therapy)
• Proctitis (drug therapy)
• Randomized Controlled Trials as Topic